The osteotropic behavior of tumor cells is driven by bone-specific metastatic signaling molecules such as matrix metalloproteinase-9 (MMP-9) and bone morphogenetic protein-7 (BMP-7), which are highly expressed in prostate and breast cancers and promote EMT and bone invasion [12,13]. Here, MMP9 is linked to breast cancer.